Myeloid Neoplasm: Clinical Trials

3 trials for Myeloid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Myeloid Neoplasm: new trials by email Literature Review of Myeloid Neoplasm trials Research Report on Myeloid Neoplasm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
Liposome-encapsulated Daunorubicin-Cytarabine, Cladribine, Cytarabine - Acute Myeloid Leukemia, Myeloid Neoplasm
Phase 2CompletedFred Hutchinson Cancer Center602020-05-272026-06-29
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
Cladribine, Cytarabine, Granulocyte Colony-Stimulating Factor - Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia
Phase 2CompletedUniversity of Washington502016-12-302022-03-08
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
Cladribine, Cyclosporine, Cytarabine - Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2
Phase 2CompletedUniversity of Washington302016-09-222021-11-08

Narrower conditions

Leukemia, Myeloid, Acute (3)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Leukemia (3)  ·  Leukemia, Myeloid (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Bone Marrow Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)

Interventions

Cladribine (3)  ·  Cytarabine (3)  ·  Mitoxantrone (3)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  2'-chloro-2'-deoxyadenosine (1)  ·  CPX-351 (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Daunorubicin (1)  ·  Filgrastim (1)  ·  Injections (1)  ·  Liposomes (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  Sirolimus (1)

Sponsors

University of Washington (2)  ·  Fred Hutchinson Cancer Center (1)

Countries

United States (3)

Top investigators

Anna Halpern (1)  ·  Mary-Elizabeth Percival (1)  ·  Roland Walter (1)

NIH funding

P30CA015704 (2)